Image may be NSFW.
Clik here to view.
Digital Health company Livongo Health said today that it is partnering with Glytec to develop a diabetes management solution that includes insulin titration. The companies plan to expand Glytec’s eGlycemic Management System to improve health outcomes in patients with diabetes.
Glytec touted that its suite of FDA-cleared dosing algorithms for IV, subcutaneous and pediatric insulin dosing already yield clinical outcomes such as insulin titration to goal in 11 days and sustained drops of A1C of 2.6%. Together, the companies hope to integrate medication data, provide medication monitoring and optimize adherence.
Get the full story at our sister site, Drug Delivery Business News.
The post Livongo, Glytec ink deal for electronic diabetes management solution appeared first on MassDevice.
